Landfar Bio-medicine Co., Ltd

Equities

000504

CNE000000263

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 22/05/2024 BST			5-day change	1st Jan Change
7.1 ^CNY	-3.01%		-7.43%	-38.79%

04-29	Landfar Bio-medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-11	Chongqing International Trust Co., Ltd. acquired 10.8% stake in Landfar Bio-medicine Co., Ltd from Shanghai Heping Dazong Equity Investment Fund Management Co., Ltd for CNY 0.03 million.	CI

Nanhua Bio-Medicine Co., Ltd. Announces Election of Director

August 09, 2018 at 04:32 pm

NanHua Bio-medicine Co., Ltd. announced election of Shi Lei, Xiang Shuanglin, Hu Rongshang and Lin Xiaohui as non-independent directors. The company also announced Xu Renhe, Shi Zhe and Cu Weihua as independent directors along with them the election of Chen Yuan and Shen Chen as supervisors.

Latest news about Landfar Bio-medicine Co., Ltd

Landfar Bio-medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Chongqing International Trust Co., Ltd. acquired 10.8% stake in Landfar Bio-medicine Co., Ltd from Shanghai Heping Dazong Equity Investment Fund Management Co., Ltd for CNY 0.03 million.	04-10	CI
Landfar Bio-medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23	CI
Landfar Bio-medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23	CI
Landfar Bio-medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23	CI
Landfar Bio Medicine’s Controlling Shareholder Boosts Stake to 30%	27/04/23	MT
Landfar Bio-medicine Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	20/04/23	CI
Landfar Bio-medicine Co., Ltd completed the acquisition of additional 29% stake in Hunan Nanhua Amspring Biotechnology Co., Ltd. from Wang Yang, Luo Yi and Changsha Aishi Pulin Information Consulting Co., Ltd. for CNY 9.7 million.	09/12/22	CI
NanHua Bio-medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	30/10/22	CI
NanHua Bio-medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	29/07/22	CI
NanHua Bio-medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22	CI
NanHua Bio-medicine Co., Ltd announced that it expects to receive CNY 275.999987 million in funding from Hunan Chasing Fund Management Co., Ltd.	21/03/22	CI
NanHua Bio-medicine Co., Ltd signed a letter of intent to acquire Medicine-related assets from YanAn Bicon Pharmaceutical Listed Company.	09/12/21	CI
NanHua Bio-medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	29/10/21	CI
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	30/08/21	CI
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	28/04/21	CI
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	30/03/21	CI
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020	28/10/20	CI
NanHua Bio-medicine Co., Ltd's Equity Buyback announced on October 29, 2019, has expired.	27/10/20	CI
Hunan Finance Industry Fund Management Co., Ltd. cancelled the acquisition of 25.58% stake in NanHua Bio-medicine Co., Ltd. from Hunan Trust Co., Ltd.	09/10/20	CI
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2020	27/08/20	CI
Nanhua Bio-Medicine Co., Ltd Announces Election of Jian Wang as Non-Independent Director	19/05/20	CI
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2020	26/04/20	CI
Shanghai Shineton Investment Co., Ltd. completed the acquisition of 54% in Hunan ProMab Biotechnologies Co., Ltd. from NanHua Bio-medicine Co., Ltd..	16/12/19	CI
Hunan Xinghui Medical Investment Management Co., Ltd. cancelled the acquisition of 10.1% stake in NanHua Bio-medicine Co., Ltd. from Shanghai Heping Large Equity Investment Fund Management Limited.	09/12/19	CI

Chart Landfar Bio-medicine Co., Ltd

Duration

Period

More charts

Company Profile

Landfar Bio medicine Co Ltd is a China-based company mainly engaged in the biomedical and energy conservation & environmental protection business. The Companyâs biomedical business includes stem cell storage and technical services, stem cell treatment research, medical instrument purchasing & sales. The Companyâs energy conservation & environmental protection business includes energy management company (EMC) contract energy management, build-transfer (BT), product sales, and sewage treatment. The Company is involved in other businesses related to aid and build project. The Company mainly conducts businesses within the domestic market.

Sector

Healthcare Facilities & Services

Calendar

08:00am - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
LANDFAR BIO-MEDICINE CO., LTD	-38.79%	334M
SONIC HEALTHCARE LIMITED	-20.70%	7.83B
DR. LAL PATHLABS LIMITED	+0.14%	2.58B
SYNLAB AG	-8.23%	2.48B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-40.47%	2.46B
NEOGENOMICS, INC.	-14.15%	1.84B
FLEURY S.A.	-20.84%	1.53B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-42.17%	1.22B
METROPOLIS HEALTHCARE LIMITED	+16.01%	1.2B
VIJAYA DIAGNOSTIC CENTRE LIMITED	+14.92%	961M

Medical & Diagnostic Laboratories